297 long-term efficacy and safety of vibegron for overactive bladder syndrome in patients ≥65 years old: analysis from the empowur extension trialD Staskin,J Frankel, S Varano, H Greene,E ThomasContinence（2022）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
